The global hemostatic gels market is set for significant expansion, driven by increasing demand for advanced wound management solutions. Valued at USD 1.0 billion in 2022, the market is expected to grow at a CAGR of 6.8%, reaching USD 1.9 billion by 2032. This growth underscores the critical role of hemostatic gels in modern healthcare, where managing blood loss effectively remains a top priority.
The Growing Need for Hemostatic Gels in Trauma and Surgical Care
Blood loss is one of the leading causes of death in trauma cases, making effective hemostatic solutions essential in both emergency and surgical settings. Hemostatic gels play a crucial role in wound management, serving as either an alternative or an assistant to conventional hemostatic devices. These gels accelerate clotting, helping to stop or control bleeding more efficiently than the body’s natural coagulation process.
Explore Market Dynamics: Request Your Sample Report Now! https://www.futuremarketinsights.com/report-sample#5245502d47422d3135303835
With advancements in biotechnology and medical science, hemostatic gels have evolved to provide faster and more reliable hemostasis, reducing the risk of complications from excessive bleeding. Their use is particularly valuable in surgical procedures, trauma cases, and military applications, where rapid blood clotting can be life-saving.
Key Market Drivers
Several factors are driving the demand for hemostatic gels, contributing to the market’s rapid growth:
- Rising Surgical Procedures – The increasing number of surgeries worldwide has escalated the need for effective bleeding control solutions. Whether in cardiovascular, orthopedic, or general surgeries, hemostatic gels are becoming a preferred option.
- Growing Trauma and Emergency Cases – The rise in accidents, injuries, and battlefield trauma has fueled the demand for rapid and effective hemostatic agents. Emergency response teams and military personnel frequently rely on hemostatic gels for quick and efficient wound management.
- Advancements in Hemostatic Technology – Innovations in biomedical engineering have led to the development of more effective and biocompatible hemostatic gels. These modern formulations enhance clotting speed and efficiency, reducing surgical risks and improving patient outcomes.
- Increased Awareness and Adoption in Healthcare Facilities – Healthcare providers are increasingly recognizing the benefits of hemostatic gels, leading to higher adoption rates in hospitals, clinics, and emergency care centers.
- Rising Demand for Minimally Invasive Procedures – With the shift towards minimally invasive surgeries (MIS), the need for fast-acting hemostatic agents has surged. Hemostatic gels provide a non-invasive, easy-to-apply solution for controlling bleeding in such procedures.
Regional Outlook
- North America is expected to lead the global hemostatic gels market, driven by a well-established healthcare infrastructure, high adoption of advanced medical technologies, and increased surgical volumes.
- Europe follows closely, with growing research and development (R&D) investments in hemostatic solutions and a strong presence of leading medical device manufacturers.
- Asia-Pacific is anticipated to witness the fastest growth rate, fueled by rising healthcare expenditures, an increasing number of surgeries, and growing awareness regarding advanced hemostatic products.
- Latin America and the Middle East & Africa are also experiencing steady growth, driven by improving healthcare access and rising demand for trauma and surgical care solutions.
Interest in Market Trends: Get Detailed Analysis and Insights with Our Comprehensive Report! https://www.futuremarketinsights.com/reports/hemostatic-gels-market
Challenges and Opportunities
Despite the promising growth trajectory, the hemostatic gels market faces certain challenges:
- High Cost of Advanced Hemostatic Products – Some hemostatic gels remain expensive, limiting their accessibility in low-income regions.
- Stringent Regulatory Approvals – Medical device regulations can delay product approvals, affecting market entry for new players.
- Risk of Allergic Reactions or Side Effects – Although rare, some patients may experience adverse reactions to hemostatic gels, requiring careful evaluation by healthcare providers.
However, these challenges also present opportunities for market players to focus on cost-effective product innovation, strategic collaborations, and enhanced R&D efforts to improve the accessibility and efficiency of hemostatic gels.
Key Takeaways:
- Based on product type, sales of porcine-based hemostatic gels are expected to grow at a 5.7% CAGR through 2032.
- In terms of indication, the cardiovascular surgery segment is expected to account for 33.1% of the total market share over the assessment period.
- By end user, demand for hemostatic gels across hospitals will increase at a 5.4% CAGR during the forecast period.
- The U.S. dominated the North America hemostatic gels market in 2021, holding 82% of the total market share.
- Demand for hemostatic gels in India is forecast to grow at a 7.4% CAGR over the assessment period.
- Sales in the U.K. hemostatic gels market are expected to increase at a 7.1% CAGR through 2032.
- China will emerge as a lucrative pocket, with demand growing at an 8% CAGR over the forecast period.
“Rising adoption of effective hemostatic gels across various industries for the protection of the workforce is expected to fuel demand in the market. In addition to this, rising awareness regarding the usage of hemostatic gels for blood loss management across emerging economies will augment the growth in the market,” says an FMI analyst
Competitive Landscape
The global hemostatic gels market is witnessing strong competition, with key players introducing innovative solutions to address the growing demand for easy-to-apply hemostatic gels. These products are particularly valuable for treating irregular fractures, where traditional bandages are impractical, and powders can be cumbersome or uncomfortable.
Recent Developments
- July 2021 – Medcura, Inc., in collaboration with ASO, LLC, launched Rapid-Seal, a high-performance, antibacterial hemostatic gel now available through multiple e-commerce platforms and a leading U.S. drugstore chain.
- December 2021 – Cresilon, Inc. submitted a 510(k) premarket notification to the U.S. FDA for its registered hemostatic gel, following the successful launch of VETIGEL, a cutting-edge hemostatic gel for veterinary applications.
With multiple players in the market, competition remains intense. To strengthen their market presence and meet evolving consumer needs, companies are leveraging strategies such as mergers, acquisitions, partnerships, and collaborations.
Strategic Moves:
- July 2021 – Baxter International Inc. acquired select assets of CryoLife, Inc., including the PerClot polysaccharide hemostatic system, in a $60.8 million transaction.
Key Companies Profiled
Baxter, Bio-Chem LLC, Clinician’s Choice Dental Products Inc., Cresilon, Inc., DSI Ltd., ENDOVISION CO., LTD, Ethicon US, LLC, F&A Medical, PrevestDenPro, Septodont, Teleflex Incorporated, Ultradent Products Inc., VladMiVa, Medcura, Inc.
Harness Healthcare Market Trends for Your Advantage! https://www.futuremarketinsights.com/industry-analysis/medical-supplies
Future Outlook and Market Expansion
With the global burden of surgical and trauma-related bleeding cases on the rise, the hemostatic gels market is poised for continuous growth. Increased investment in biotechnology, along with technological advancements in hemostasis, will further drive market expansion.
Additionally, the integration of nanotechnology and bioengineered hemostatic solutions may revolutionize the market, offering more effective and patient-friendly products.
The global hemostatic gels market is on a steady growth path, with its value projected to reach USD 1.9 billion by 2032. With rising surgical procedures, increasing trauma cases, and continuous advancements in hemostatic technology, the demand for innovative hemostatic gels is set to soar.
As healthcare providers and medical device manufacturers continue to explore cutting-edge solutions for efficient blood loss management, hemostatic gels will remain a critical component in trauma care, surgical procedures, and emergency medicine.
With increasing adoption across healthcare facilities worldwide, the future of the hemostatic gels market looks promising, offering immense opportunities for growth and innovation in the coming decade.
Key Market Segments Covered In Hemostatic Gels Industry Research
By Material:
- Bovine-Based
- Porcine-Based
- Polymer-Based
By Indication:
- General Surgery
- Dental Surgery
- Veterinary Surgery
- Cardiovascular Surgery
- Orthopaedic Surgery
- Others
By End-User:
- Hospitals
- Speciality Clinics
- Veterinary Settings
- Ambulatory Surgical Centers
- Online Sales
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
